Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 47.19 K87.17 K152.96 K178.74 K 466.06 K Research & development ———— — Operating income -47.19 K-87.17 K-152.96 K-178.74 K -466.06 K Non-Operating Income, Total 0-273.52 K2.26 M2.11 M 4.1 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 0-273.52 K2.26 M2.11 M 4.1 M Unusual income/expense ———— — Pretax income -47.19 K-360.69 K2.11 M1.93 M 3.63 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -47.19 K-360.69 K2.11 M1.93 M 3.63 M Discontinued operations ———— — Net income -47.19 K-360.69 K2.11 M1.93 M 3.63 M Dilution adjustment ——217.98 M— — Preferred dividends ——217.98 M— — Diluted net income available to common stockholders 47.19 K360.69 K2.11 M1.12 M 3.63 M Basic earnings per share (Basic EPS) -0.01-0.040.070.17 0.19 Diluted earnings per share (Diluted EPS) -0.01-0.040.070.16 0.18 Average basic shares outstanding 6.88 M6.93 M7.51 M7.77 M 49.9 M Diluted shares outstanding 6.88 M7.93 M8.14 M8.03 M 51.79 M EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —